Neurothera Labs Inc (NTLX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
| 01-2023 | 10-2022 | 07-2022 | 04-2022 | 01-2022 | |
| Operating Expenses | 14 | 11 | 28 | 25 | 51 |
| Operating Income | -14 | -11 | -28 | -25 | -31 |
| Other Income | 0 | 0 | 0 | 0 | -3 |
| Pre-tax Income | -14 | -11 | -28 | -25 | -34 |
| Net Income Continuous | -14 | -11 | -28 | -25 | -34 |
| Net Income | $-14 | $-11 | $-28 | $-25 | $-34 |
| EBITDA(a) | $-14 | $-11 | $-28 | $-25 | $-31 |